263 related articles for article (PubMed ID: 38148844)
1. Vascular co-option in resistance to anti-angiogenic therapy.
Ribatti D; Annese T; Tamma R
Front Oncol; 2023; 13():1323350. PubMed ID: 38148844
[TBL] [Abstract][Full Text] [Related]
2. Vascular Co-Option and Other Alternative Modalities of Growth of Tumor Vasculature in Glioblastoma.
Ribatti D; Pezzella F
Front Oncol; 2022; 12():874554. PubMed ID: 35433447
[TBL] [Abstract][Full Text] [Related]
3. Overview on the Different Patterns of Tumor Vascularization.
Ribatti D; Pezzella F
Cells; 2021 Mar; 10(3):. PubMed ID: 33805699
[TBL] [Abstract][Full Text] [Related]
4. Vascular Growth in Lymphomas: Angiogenesis and Alternative Ways.
Ribatti D; Tamma R; Annese T; d'Amati A; Ingravallo G; Specchia G
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370872
[TBL] [Abstract][Full Text] [Related]
5. Co-option of Liver Vessels and Not Sprouting Angiogenesis Drives Acquired Sorafenib Resistance in Hepatocellular Carcinoma.
Kuczynski EA; Yin M; Bar-Zion A; Lee CR; Butz H; Man S; Daley F; Vermeulen PB; Yousef GM; Foster FS; Reynolds AR; Kerbel RS
J Natl Cancer Inst; 2016 Aug; 108(8):. PubMed ID: 27059374
[TBL] [Abstract][Full Text] [Related]
6. Different Forms of Tumor Vascularization and Their Clinical Implications Focusing on Vessel Co-option in Colorectal Cancer Liver Metastases.
Haas G; Fan S; Ghadimi M; De Oliveira T; Conradi LC
Front Cell Dev Biol; 2021; 9():612774. PubMed ID: 33912554
[TBL] [Abstract][Full Text] [Related]
7. Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.
Bridgeman VL; Vermeulen PB; Foo S; Bilecz A; Daley F; Kostaras E; Nathan MR; Wan E; Frentzas S; Schweiger T; Hegedus B; Hoetzenecker K; Renyi-Vamos F; Kuczynski EA; Vasudev NS; Larkin J; Gore M; Dvorak HF; Paku S; Kerbel RS; Dome B; Reynolds AR
J Pathol; 2017 Feb; 241(3):362-374. PubMed ID: 27859259
[TBL] [Abstract][Full Text] [Related]
8. Vessel co-option: how tumors obtain blood supply in the absence of sprouting angiogenesis.
Leenders WP; Küsters B; de Waal RM
Endothelium; 2002; 9(2):83-7. PubMed ID: 12200959
[TBL] [Abstract][Full Text] [Related]
9. Resistance Mechanisms of Anti-angiogenic Therapy and Exosomes-Mediated Revascularization in Cancer.
Zeng Y; Fu BM
Front Cell Dev Biol; 2020; 8():610661. PubMed ID: 33363174
[TBL] [Abstract][Full Text] [Related]
10. Tumour vascularization: sprouting angiogenesis and beyond.
Hillen F; Griffioen AW
Cancer Metastasis Rev; 2007 Dec; 26(3-4):489-502. PubMed ID: 17717633
[TBL] [Abstract][Full Text] [Related]
11. Vascular co-option and vasculogenic mimicry mediate resistance to antiangiogenic strategies.
Pezzella F; Ribatti D
Cancer Rep (Hoboken); 2022 Dec; 5(12):e1318. PubMed ID: 33295149
[TBL] [Abstract][Full Text] [Related]
12. The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer.
Ribatti D; Solimando AG; Pezzella F
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298648
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis in NSCLC: is vessel co-option the trunk that sustains the branches?
Coelho AL; Gomes MP; Catarino RJ; Rolfo C; Lopes AM; Medeiros RM; Araújo AM
Oncotarget; 2017 Jun; 8(24):39795-39804. PubMed ID: 26950275
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of angiogenesis in tumour.
Zhang R; Yao Y; Gao H; Hu X
Front Oncol; 2024; 14():1359069. PubMed ID: 38590656
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis.
Cao Z; Shang B; Zhang G; Miele L; Sarkar FH; Wang Z; Zhou Q
Biochim Biophys Acta; 2013 Dec; 1836(2):273-86. PubMed ID: 23933263
[TBL] [Abstract][Full Text] [Related]
16. The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers.
Shao Y; Lu B
Cancer Metastasis Rev; 2022 Mar; 41(1):173-191. PubMed ID: 34664157
[TBL] [Abstract][Full Text] [Related]
17. Vessel co-option and resistance to anti-angiogenic therapy.
Kuczynski EA; Reynolds AR
Angiogenesis; 2020 Feb; 23(1):55-74. PubMed ID: 31865479
[TBL] [Abstract][Full Text] [Related]
18. The role and therapeutic potential of endothelial progenitor cells in tumor neovascularization.
Janic B; Arbab AS
ScientificWorldJournal; 2010 Jun; 10():1088-99. PubMed ID: 20563532
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of vascularization in murine models of primary and metastatic tumor growth.
Bugyik E; Renyi-Vamos F; Szabo V; Dezso K; Ecker N; Rokusz A; Nagy P; Dome B; Paku S
Chin J Cancer; 2016 Feb; 35():19. PubMed ID: 26873579
[TBL] [Abstract][Full Text] [Related]
20. Intussusceptive angiogenesis: a biologically relevant form of angiogenesis.
De Spiegelaere W; Casteleyn C; Van den Broeck W; Plendl J; Bahramsoltani M; Simoens P; Djonov V; Cornillie P
J Vasc Res; 2012; 49(5):390-404. PubMed ID: 22739226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
